Physician profile
George King
NPI 1760822084
$3,620.48
in general payments reported to CMS, 2019-2025
16 companies · $411 in 2025
The $411 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $617 · 2022: $1,364 · 2023: $862 · 2024: $366 · 2025: $411.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,639.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,639.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,347.43 | 2021-2024 | |
| Axsome Therapeutics, INC. | $573.27 | 2022-2025 | Auvelity |
| Neurocrine Biosciences, INC. | $440.94 | 2021-2023 | Ingrezza |
| Alkermes, INC. | $297.74 | 2023-2025 | Lybalvi, Aristada |
| Otsuka America Pharmaceutical, INC. | $292.22 | 2021-2023 | Rexulti, Abilify Maintena |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $191.46 | 2021-2023 | |
| Corium, LLC | $174.74 | 2022-2023 | Azstarys |
| Pfizer INC. | $72.02 | 2023 | |
| Abbott Laboratories | $54.89 | 2021-2022 | |
| Evofem Biosciences, INC. | $49.82 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $37.63 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $22.20 | 2022 | |
| Lundbeck LLC | $18.10 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $17.12 | 2025 | Cobenfy |
| Novartis Pharmaceuticals Corporation | $16.90 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $14.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.